首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Clinical observations with long-term atrial pacing.
【24h】

Clinical observations with long-term atrial pacing.

机译:长期心房起搏的临床观察。

获取原文
获取原文并翻译 | 示例
       

摘要

Atrial pacing (AP), despite its beneficial hemodynamic and antiarrhythmic effect, is still an underused mode of stimulation. The main purpose of this study was to evaluate the long-term results of AP. Sixty four patients (pts) with sinus node disease (28 male and 36 female: mean age 54.2; range: 44-88 years), 3.2% of the total implantation at our clinic were treated with AP between 1982-96. Criteria for atrial pacing were: no AV block in the history, no AV-block during carotid sinus massage, Wenckebach point > 130/min, left atrium < 50 mm, left ventricular EF > 40%. The indication for pacing was predominant sinus bradycardia (SB) in 34 pts and tachycardia-bradycardia syndrome (TBS) in 30 pts. Pts with TBS were on antiarrhythmic treatment, while most pts with SB received no antiarrhythmic drugs. All the pts were checked up at every 3-6 month. Sixty-two pts were followed for 3-154 (mean: 67) months, two pts were lost for follow-up. Repeated lead dislodgment occurred in two pts, which made a pacing mode change necessary. Four pts died during the follow-up period for non-cardiac reasons. At the end of the follow-up period the data of 60 pts were available for evaluation (33 pts with SB, 27 pts with TBS). All the pts with SB were in sinus rhythm, and no patient developed AV block by the end of the follow-up period. Seven out of 27 pts with TBS developed chronic atrial fibrillation, 3 out of them suffered a cerebral embolism; the remaining 20 pts were in sinus rhythm, and the number of paroxysmal attacks decreased significantly, which improved their quality of life significantly. Three pts in this group developed a temporary complete AV block, which regressed with decreasing the dosage of antiarrhythmic drugs. Atrial pacing is proved to be a safe and reliable treatment for sick sinus syndrome. Proper patient selection is crucial in preventing the development of AV conduction disturbance. Atrial stimulation had a satisfactory long-term antiarrhythmic effect in pts with sick sinus syndrome (SSS).
机译:心房起搏(AP),尽管它具有有益的血液动力学和抗心律失常作用,但仍然是一种未被充分利用的刺激方式。这项研究的主要目的是评估AP的长期结果。 1982-96年间,有64例窦房结疾病患者(男28例,女36例:平均年龄54.2;范围:44-88岁)接受了AP治疗,占我们总植入量的3.2%。心房起搏的标准为:历史上无房室传导阻滞,颈动脉窦按摩期间无房室传导阻滞,Wenckebach点> 130 / min,左心房<50 mm,左心室EF> 40%。起搏的指征主要是窦性心动过缓(SB)34分,心动过速-心动过缓综合征(TBS)30分。患有TBS的患者接受抗心律不齐治疗,而大多数患有SB的患者未接受抗心律不齐药物治疗。每3-6个月检查一次所有患者。随访了32分,共3-154分(平均67次),失访了2分。两次重复发生铅移位,这使得必须更改起搏模式。在随访期间有四名患者因非心脏原因死亡。在随访期结束时,有60分的数据可供评估(SB分33分,TBS分27分)。所有SB的患者均处于窦性心律,并且在随访期末没有患者出现房室传导阻滞。患有TBS的27例患者中有7例发生了慢性房颤,其中3例患有脑栓塞。其余20分处于窦性心律,阵发性发作次数明显减少,从而显着改善了他们的生活质量。该组中的三名患者出现了暂时性完全性房室传导阻滞,并随着抗心律失常药物剂量的减少而退缩。心房起搏已被证明是一种安全可靠的治疗病态窦房结综合征的方法。正确的患者选择对于预防AV传导障碍的发展至关重要。心房刺激对患有病态窦房结综合征(SSS)的患者具有令人满意的长期抗心律不齐作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号